Back to results
US 2026/0294965 A1Published application
Method for Treating Liver Cancer Using Cell-Immune Agent Composition Delivered via Hepatic Artery
AssigneeNational Defense Medical University
InventorsBing-Heng YANG, Wei-Chen HUANG
Life of this patent
Estimating the term…
Abstract
The present invention disclosed a method for treating liver cancer in a subject in need thereof. The method includes administering autologous immune cells and immune checkpoint inhibitors to a subject via hepatic artery injection.
Claims17
A method for treating liver cancer in a subject in need thereof, comprising:
- administering a therapeutically effective amount of autologous immune cells to the subject;
- and
- administering a therapeutically effective amount of an ICI to the subject;
- wherein the therapeutically effective amount of the autologous immune cells and the therapeutically effective amount of the immune checkpoint inhibitor are administered to the subject via hepatic artery infusion.
1 more element
Dependencies are inferred from the claim text.